Inventor
VENKAIAH CHOWDARY NANNAPANENI
IN22 patents
⚠️ This page may combine multiple inventors who share the name “VENKAIAH CHOWDARY NANNAPANENI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NATCO PHARMA LTD
12 patentsUS7960545B2Jun 14, 2011
Process for the prepartion of erlotinib
NATCO PHARMA LTD10 citations77
US7910598B2Mar 22, 2011
Phenylaminopyrimidine derivatives as inhibitors of BCR-ABL kinase
NATCO PHARMA LTD5 citations69
US11498902B2Nov 15, 2022
Process for the preparation of Cabozantinib and its pharmaceutically acceptable salts thereof
NATCO PHARMA LTD6 citations63
US8048883B2Nov 1, 2011
Polymorphic form of imatinib mesylate and a process for its preparation
NATCO PHARMA LTD3 citations55
US11576917B2Feb 14, 2023
Pharmaceutical compositions comprising Ibrutinib
NATCO PHARMA LTD0 citations50
US11452722B2Sep 27, 2022
Stable pharmaceutical compositions comprising lenalidomide
NATCO PHARMA LTD0 citations50
US8748602B2Jun 10, 2014
Polymorphs of erlotinib hydrochloride and method of preparation
NATCO PHARMA LTD0 citations50
US8349855B2Jan 8, 2013
Polymorphs of erlotinib hydrochloride and method of preparation
NATCO PHARMA LTD0 citations50
US11730753B2Aug 22, 2023
Stable pharmaceutical compositions comprising trifluridine and tipiracil hydrochloride
NATCO PHARMA LTD0 citations49
US9481655B2Nov 1, 2016
6,7-dialkoxy quinazoline derivatives and methods of treating drug resistant and other tumors
NATCO PHARMA LTD0 citations49
US7939541B2May 10, 2011
Intermediates and a process employing the intermediates for the preparation of (3-trifluoromethylsulfonyl)-N-[4-methyl-3-(4-pyridin-3yl-pyrimidin-2ylamino)-phenyl]-benzamide
NATCO PHARMA LTD1 citations49
US11845811B2Dec 19, 2023
Process for the preparation of Sugammadex sodium and its novel polymorphic form
NATCO PHARMA LTD0 citations34